{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:09:38Z","timestamp":1774868978320,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006327","name":"National Institute of Radiological Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006327","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["physicamedica.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physica Medica"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ejmp.2018.04.391","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T14:05:35Z","timestamp":1524578735000},"page":"48-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Monte Carlo study of out-of-field exposure in carbon-ion radiotherapy with a passive beam: Organ doses in prostate cancer treatment"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9539-7597","authenticated-orcid":false,"given":"Shunsuke","family":"Yonai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naruhiro","family":"Matsufuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Akahane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmp.2018.04.391_b0005","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejmp.2018.04.391_b0010","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1442-2042.2012.02961.x","article-title":"Carbon-ion radiation therapy for prostate cancer","volume":"19","author":"Ishikawa","year":"2012","journal-title":"Int J Urol"},{"key":"10.1016\/j.ejmp.2018.04.391_b0015","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1038\/bjc.2014.191","article-title":"Phase I\/II trial of definitive carbon ion radiotherapy for prostate cancer: evaluation of shortening of treatment period to 3 weeks","volume":"110","author":"Nomiya","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejmp.2018.04.391_b0020","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/jjco\/hys104","article-title":"A review of update clinical results of carbon ion radiotherapy","volume":"42","author":"Tsujii","year":"2012","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ejmp.2018.04.391_b0025","doi-asserted-by":"crossref","first-page":"20130626","DOI":"10.1259\/bjr.20130626","article-title":"New challenges in high-energy particle radiobiology","volume":"87","author":"Durante","year":"2014","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ejmp.2018.04.391_b0030","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejmp.2017.10.004","article-title":"Risk of second cancer following radiotherapy","volume":"42","author":"Toma-Dasu","year":"2017","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2018.04.391_b0035","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejmp.2017.04.022","article-title":"Radiation-induced cancer risk predictions in proton and heavy ion radiotherapy","volume":"42","author":"Stokkevag","year":"2017","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2018.04.391_b0040","unstructured":"National Council on Radiation Protection and Measurements (NCRP). Second primary cancers and cardiovascular disease after radiation therapy. Report 170. 2011; Bethesda, MD, US."},{"key":"10.1016\/j.ejmp.2018.04.391_b0045","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nrc3069","article-title":"Assessing the risk of second malignancies after modern radiotherapy","volume":"11","author":"Newhauser","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejmp.2018.04.391_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijrobp.2006.01.027","article-title":"Intensity-modulated radiation therapy, protons, and the risk of second cancers","volume":"65","author":"Hall","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2018.04.391_b0055","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.ijrobp.2004.12.091","article-title":"Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy","volume":"62","author":"Kry","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2018.04.391_b0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ejmp.2017.02.018","article-title":"The risk of second primary cancers due to peripheral photon and neutron doses received during prostate cancer external beam radiation therapy","volume":"42","author":"Bezak","year":"2017","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2018.04.391_b0065","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.1118\/1.2989019","article-title":"Measurement of neutron ambient dose equivalent in passive carbon-ion and proton radiotherapies","volume":"35","author":"Yonai","year":"2008","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2018.04.391_b0070","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1118\/1.3458721","article-title":"Measurement of absorbed dose, quality factor, and dose equivalent in water phantom outside of the irradiation field in passive carbon-ion and proton radiotherapies","volume":"37","author":"Yonai","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2018.04.391_b0075","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/02841860510029833","article-title":"The use of risk estimation models for the induction of secondary cancers following radiotherapy","volume":"44","author":"Dasu","year":"2005","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejmp.2018.04.391_b0080","doi-asserted-by":"crossref","first-page":"A143","DOI":"10.1088\/0952-4746\/29\/2A\/S10","article-title":"Modelling carcinogenesis after radiotherapy suing Poisson statistics; implications for IMRT, protons and ions","volume":"29","author":"Jones","year":"2009","journal-title":"J Radiol Prot"},{"key":"10.1016\/j.ejmp.2018.04.391_b0085","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejmp.2017.03.011","article-title":"Risk of secondary cancers: bridging epidemiology and modeling","volume":"42","author":"Schneider","year":"2017","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2018.04.391_b0090","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejmp.2017.02.015","article-title":"Models for the risk of secondary cancers from radiation therapy","volume":"42","author":"Dasu","year":"2017","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2018.04.391_b0095","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1088\/0031-9155\/53\/6\/012","article-title":"Equivalent dose and effective dose from stray radiation during passively scattered proton radiotherapy for prostate cancer","volume":"53","author":"Fontenot","year":"2008","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2018.04.391_b0100","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00066-006-1534-8","article-title":"The impact of IMRT and proton radiotherapy on secondary cancer incidence","volume":"182","author":"Schneider","year":"2006","journal-title":"Strahlentherapie Und Onkol"},{"key":"10.1016\/j.ejmp.2018.04.391_b0105","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ijrobp.2009.01.001","article-title":"Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer","volume":"74","author":"Fontenot","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2018.04.391_b0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejmp.2017.07.003","article-title":"Radiobiological evaluation of prostate cancer IMRT and conformal-RT plans using different treatment protocols","volume":"40","author":"Mavroidis","year":"2017","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2018.04.391_b0115","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.radonc.2013.12.012","article-title":"Second primary cancers after radiation for prostate cancer: a systematic review of the clinical data and impact of treatment technique","volume":"110","author":"Murray","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2018.04.391_b0120","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1118\/1.4736823","article-title":"Calculation of out-of-field dose distribution in carbon-ion radiotherapy by Monte Carlo simulation","volume":"39","author":"Yonai","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2018.04.391_b0125","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0167-5087(83)90621-X","article-title":"Three-dimensional beam scanning for proton therapy","volume":"214","author":"Kanai","year":"1983","journal-title":"Nucl Instrum Methods Phys Res"},{"key":"10.1016\/j.ejmp.2018.04.391_b0130","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0168-9002(93)91335-K","article-title":"Magnetic scanning system for heavy ion therapy","volume":"330","author":"Haberer","year":"1993","journal-title":"Nucl Instrum Methods Phys Res A"},{"key":"10.1016\/j.ejmp.2018.04.391_b0135","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.nimb.2013.12.036","article-title":"Recent progress of HIMAC for sophisticated heavy-ion cancer radiotherapy","volume":"331","author":"Noda","year":"2014","journal-title":"Nucl Instruments Methods Phys Res Sect B Beam Interact with Mater Atoms"},{"key":"10.1016\/j.ejmp.2018.04.391_b0140","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.nimb.2017.04.021","article-title":"Recent progress and future plans of heavy-ion cancer radiotherapy with HIMAC","volume":"406","author":"Noda","year":"2017","journal-title":"Nucl Instruments Methods Phys Res Sect B Beam Interact with Mater Atoms"},{"key":"10.1016\/j.ejmp.2018.04.391_b0145","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1118\/1.2836953","article-title":"Evaluation of beam wobbling methods for heavy-ion radiotherapy","volume":"35","author":"Yonai","year":"2008","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2018.04.391_b0150","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1118\/1.3220624","article-title":"Monte Carlo study on secondary neutrons in passive carbon-ion radiotherapy: identification of the main source and reduction in the secondary neutron dose","volume":"36","author":"Yonai","year":"2009","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2018.04.391_b0155","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1080\/00223131.2013.814553","article-title":"Particle and heavy ion transport code system, PHITS, version 2.52","volume":"50","author":"Sato","year":"2013","journal-title":"J Nucl Sci Technol"},{"key":"10.1016\/j.ejmp.2018.04.391_b0160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s004110050124","article-title":"Neutron, proton, and photonuclear cross-sections for radiation therapy and radiation protection","volume":"37","author":"Chadwick","year":"1998","journal-title":"Radiat Environ Biophys"},{"key":"10.1016\/j.ejmp.2018.04.391_b0165","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1080\/18811248.2002.9715303","article-title":"Japanese evaluated nuclear data library version 3 revision-3: JENDL-3.3","volume":"39","author":"Shibata","year":"2002","journal-title":"J Nucl Sci Technol"},{"key":"10.1016\/j.ejmp.2018.04.391_b0170","unstructured":"International Commission on Radiological Protection. Adult reference computational phantoms. ICRP publication 110. Ann ICRP. 2009;39."},{"key":"10.1016\/j.ejmp.2018.04.391_b0175","unstructured":"International Commission on Radiological Protection. The 2007 recommendations of the international commission on radiological protection. ICRP Publication 103. Ann ICRP. 2007;37."},{"key":"10.1016\/j.ejmp.2018.04.391_b0180","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.radonc.2015.11.023","article-title":"Estimation of late rectal normal tissue complication probability parameters in carbon ion therapy for prostate cancer","volume":"118","author":"Fukahori","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2018.04.391_b0185","unstructured":"International Commission on Radiological Protection. 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Ann ICRP. 1991;21."},{"key":"10.1016\/j.ejmp.2018.04.391_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1118\/1.4791647","article-title":"Calculated organ doses using Monte Carlo simulations in a reference male phantom undergoing HDR brachytherapy applied to localized prostate carcinoma","volume":"40","author":"Candela-juan","year":"2013","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2018.04.391_b0195","doi-asserted-by":"crossref","unstructured":"International Commission on Radiological Protection. Relative Biological Effectiveness (RBE), Quality Factor (Q), and Radiation Weighting Factor (wR). ICRP publication 92. Ann ICRP. 2003;33.","DOI":"10.1016\/S0146-6453(03)00024-1"},{"key":"10.1016\/j.ejmp.2018.04.391_b0200","doi-asserted-by":"crossref","unstructured":"International Commission on Radiological Protection. Radiological Protection in Ion Beam Radiotherapy. ICRP publication 127. Ann ICRP. 2014;43.","DOI":"10.1177\/0146645314559144"},{"key":"10.1016\/j.ejmp.2018.04.391_b0205","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ejmp.2016.03.017","article-title":"What can particle therapy add to the treatment of prostate cancer?","volume":"32","author":"Schwarz","year":"2016","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2018.04.391_b0210","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejmp.2016.12.001","article-title":"Effect of patient positioning on carbon-ion therapy planned dose distribution to pancreatic tumors and organs at risk","volume":"33","author":"Miki","year":"2017","journal-title":"Phys Med"},{"issue":"12","key":"10.1016\/j.ejmp.2018.04.391_b0215","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.ejmp.2016.11.009","article-title":"Gated carbon-ion scanning treatment for pancreatic tumour with field specific target volume and organs at risk","volume":"32","author":"Miki","year":"2016","journal-title":"Phys Med"}],"container-title":["Physica Medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179718304502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179718304502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T07:59:50Z","timestamp":1720252790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1120179718304502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":43,"alternative-id":["S1120179718304502"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmp.2018.04.391","relation":{},"ISSN":["1120-1797"],"issn-type":[{"value":"1120-1797","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monte Carlo study of out-of-field exposure in carbon-ion radiotherapy with a passive beam: Organ doses in prostate cancer treatment","name":"articletitle","label":"Article Title"},{"value":"Physica Medica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmp.2018.04.391","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}